Financial Consulate’s Encompass Health EHC Stock Holding History

Financial Consulate’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$636	–	1380
2025 Q3	$636	Buy	+5	New	+$595	﹤0.01%	938

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Financial Consulate's EHC Position: Q4 2025 in Review

Financial Consulate sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 5 shares — an estimated $636 sold.

Financial Consulate first reported a position in EHC in Q3 2025 and held it in 1 quarter. The position peaked at $636 in Q3 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

Financial Consulate reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
Financial Consulate sold 5 Encompass Health shares in Q4 2025, an estimated $636.
Financial Consulate first reported a position in Encompass Health in Q3 2025 and held it in 1 quarter.
Financial Consulate's Encompass Health position peaked at $636 in Q3 2025.
594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Financial Consulate's 13F filing for Q4 2025, filed 22 Jan 2026.